BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15609320)

  • 1. Treatment of multi-focal colorectal carcinoma metastatic to the liver of immune-competent and syngeneic rats by hepatic artery infusion of oncolytic vesicular stomatitis virus.
    Shinozaki K; Ebert O; Woo SL
    Int J Cancer; 2005 Apr; 114(4):659-64. PubMed ID: 15609320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolysis of multifocal hepatocellular carcinoma in the rat liver by hepatic artery infusion of vesicular stomatitis virus.
    Shinozaki K; Ebert O; Kournioti C; Tai YS; Woo SL
    Mol Ther; 2004 Mar; 9(3):368-76. PubMed ID: 15006603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eradication of advanced hepatocellular carcinoma in rats via repeated hepatic arterial infusions of recombinant VSV.
    Shinozaki K; Ebert O; Woo SL
    Hepatology; 2005 Jan; 41(1):196-203. PubMed ID: 15619242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolysis of hepatic metastasis of colorectal cancer by recombinant vesicular stomatitis virus in immune-competent mice.
    Huang TG; Ebert O; Shinozaki K; García-Sastre A; Woo SL
    Mol Ther; 2003 Sep; 8(3):434-40. PubMed ID: 12946316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic alpha interferon treatment increases the therapeutic index of oncolytic vesicular stomatitis virus virotherapy for advanced hepatocellular carcinoma in immune-competent rats.
    Shinozaki K; Ebert O; Suriawinata A; Thung SN; Woo SL
    J Virol; 2005 Nov; 79(21):13705-13. PubMed ID: 16227290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of recombinant vesicular stomatitis virus-mediated virotherapy against metastatic colon cancer.
    Yamaki M; Shinozaki K; Sakaguchi T; Meseck M; Ebert O; Ohdan H; Woo SL
    Int J Mol Med; 2013 Feb; 31(2):299-306. PubMed ID: 23232984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice.
    Ebert O; Harbaran S; Shinozaki K; Woo SL
    Cancer Gene Ther; 2005 Apr; 12(4):350-8. PubMed ID: 15565179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic vesicular stomatitis virus for treatment of orthotopic hepatocellular carcinoma in immune-competent rats.
    Ebert O; Shinozaki K; Huang TG; Savontaus MJ; García-Sastre A; Woo SL
    Cancer Res; 2003 Jul; 63(13):3605-11. PubMed ID: 12839948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-12 expression enhances vesicular stomatitis virus oncolytic therapy in murine squamous cell carcinoma.
    Shin EJ; Wanna GB; Choi B; Aguila D; Ebert O; Genden EM; Woo SL
    Laryngoscope; 2007 Feb; 117(2):210-4. PubMed ID: 17204993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells.
    Altomonte J; Wu L; Meseck M; Chen L; Ebert O; Garcia-Sastre A; Fallon J; Mandeli J; Woo SL
    Cancer Gene Ther; 2009 Mar; 16(3):266-78. PubMed ID: 18846115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syncytia induction enhances the oncolytic potential of vesicular stomatitis virus in virotherapy for cancer.
    Ebert O; Shinozaki K; Kournioti C; Park MS; García-Sastre A; Woo SL
    Cancer Res; 2004 May; 64(9):3265-70. PubMed ID: 15126368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exponential enhancement of oncolytic vesicular stomatitis virus potency by vector-mediated suppression of inflammatory responses in vivo.
    Altomonte J; Wu L; Chen L; Meseck M; Ebert O; García-Sastre A; Fallon J; Woo SL
    Mol Ther; 2008 Jan; 16(1):146-53. PubMed ID: 18071337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-arterial delivery of a recombinant adenovirus does not increase gene transfer to tumor cells in a rat model of metastatic colorectal carcinoma.
    Maron DJ; Tada H; Moscioni AD; Tazelaar J; Fraker DL; Wilson JM; Spitz FR
    Mol Ther; 2001 Jul; 4(1):29-35. PubMed ID: 11472103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints.
    Reid T; Galanis E; Abbruzzese J; Sze D; Wein LM; Andrews J; Randlev B; Heise C; Uprichard M; Hatfield M; Rome L; Rubin J; Kirn D
    Cancer Res; 2002 Nov; 62(21):6070-9. PubMed ID: 12414631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer.
    Hadaschik BA; Zhang K; So AI; Fazli L; Jia W; Bell JC; Gleave ME; Rennie PS
    Cancer Res; 2008 Jun; 68(12):4506-10. PubMed ID: 18559493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I/II study of hepatic artery infusion with wtp53-CMV-Ad in metastatic malignant liver tumours.
    Habib NA; Hodgson HJ; Lemoine N; Pignatelli M
    Hum Gene Ther; 1999 Aug; 10(12):2019-34. PubMed ID: 10466636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical protocol. Tumor site specific phase I evaluation of safety and efficacy of hepatic arterial infusion of a matrix-targeted retroviral vector bearing a dominant negative cyclin G1 construct as intervention for colorectal carcinoma metastatic to liver.
    Lenz HJ; Anderson WF; Hall FL; Gordon EM
    Hum Gene Ther; 2002 Aug; 13(12):1515-37. PubMed ID: 12215272
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase I, open-label, dose-escalating study of a genetically engineered herpes simplex virus, NV1020, in subjects with metastatic colorectal carcinoma to the liver.
    Kemeny N; Brown K; Covey A; Kim T; Bhargava A; Brody L; Guilfoyle B; Haag NP; Karrasch M; Glasschroeder B; Knoll A; Getrajdman G; Kowal KJ; Jarnagin WR; Fong Y
    Hum Gene Ther; 2006 Dec; 17(12):1214-24. PubMed ID: 17107303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic tumor cells detection and anti-metastatic potential with vesicular stomatitis virus in immunocompetent murine model of osteosarcoma.
    Johan MP; Kubo T; Furuta T; Sakuda T; Sakaguchi T; Nakanishi M; Ochi M; Adachi N
    J Orthop Res; 2018 Sep; 36(9):2562-2569. PubMed ID: 29637599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207).
    Kooby DA; Carew JF; Halterman MW; Mack JE; Bertino JR; Blumgart LH; Federoff HJ; Fong Y
    FASEB J; 1999 Aug; 13(11):1325-34. PubMed ID: 10428757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.